| ACE2 | Angiotensin converting enzyme 2 |
| CD4+T cells | Cluster of differentiation 4 T helper cells |
| CXCL 9, 10, 11 | Chemokines 9, 10, 11 |
| DFT | Density functional theory |
| FADD | Fas-associated protein with death domain |
| GPX4 | Glutathione peroxidase 4 |
| HSP 60, 70,90 | Heat shock protein 60, 70,90 |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| IRF | Interferon |
| JAK1 | Janus Kinase 1 |
| LAP | LC3-associated phagocytosis |
| MHCI | major histocompatibility complex |
| MLKL | Mixed lineage kinase domain like pseudokinase |
| MMP-9 | Matrix metallopeptidase 9 |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK-cells | Natural killer cells |
| NO | Nitric oxide |
| NRF2 | Nuclear factor erythroid-derived 2-like 2 |
| P53 | Tumor protein P53 |
| PARP | Poly (ADP-ribose) polymerase |
| PI3K/AKT/mTOR pathway | Phosphatidylinositol 3-kinases/lpha serine/threonine-protein kinase/mammalian target of rapamycin |
| ROS | Reactive oxygen species |
| Se | Selenium |
| Sec | Selenocysteine |
| SELENO | Selenoprotein |
| STAT1 | Signal transducer and activator of transcription 1 |
| TLR2,4 | Toll-like receptor 2,4 |
| TNFα | Tumor necrosis factor α |
| TXNRD1,2,3 | Thioredoxin reductase 1,2,3 |